Developing and Implementing HPV SCREENED
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorRutgers, The State University of New Jersey
About this trial
This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emergency department (ED). Eligible participants will receive education and an HPV self-sampling kit to complete in the ED. Individuals with HPV-positive results will be guided to follow-up care at a local clinic.
Eligibility criteria
Qualifiers
biological women,
no prior hysterectomy or cervical cancer,
not pregnant,
last Pap >3 years, last co-test >5 years, or last HPV alone test >5 years,
Disqualifiers
currently pregnant (as diagnostic procedures for cervical cancer are often deferred during pregnancy);
previous hysterectomy;
previous diagnosis of cervical cancer;
current menses
Trial design
Treatments tested in this trial
- HPV Self-collection in the ED
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov